Ledger.Open graph →
SEC Form D · filed October 10, 2014

ASPEN PARK PHARMACEUTICALS, INC

Offering
$20.0M
Sold
—
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (5)

Mitchell S. Steiner · New York, NYExec · DirectorSteven J. Anderson · Southlake, TXExec · DirectorHarry S. Fisch, Md · New York, NYExec · DirectorRodman E. Van Sciver · Andover, MAExec · DirectorHarry S. Fisch, Md · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗